Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. RB705 Rat Anti-Mouse CD62L (L-Selectin), BD Horizon™

RB705 Rat Anti-Mouse CD62L (L-Selectin), BD Horizon™

Catalog No. BDB570282 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.1 mg
25 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB570282 0.1 mg
BDB570283 25 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. BDB570282 Supplier BD Biosciences Supplier No. 570282
Only null left
Add to Cart
Add to Cart

Description

Rat Monoclonal Antibody

CD62L (L-Selectin) Monoclonal antibody specifically detects CD62L (L-Selectin) in Mouse samples. It is validated for Flow cytometry
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD62L (L-Selectin)
Applications Flow Cytometry
Classification Monoclonal
Clone MEL-14
Concentration 0.2 mg/mL
Conjugate RB705
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias Sell; L-selectin; LECAM-1; LAM-1; Lnhr; Ly-22; Ly-m22; Lyam-1
Host Species Rat
Immunogen C3H/eb mouse B lymphoma 38C-13
Purification Method Affinity Chromatography
Quantity 0.1 mg
Regulatory Status RUO
Gene ID (Entrez) 20343
Target Species Mouse
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Form Liquid
Isotype IgG2a κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.